The Only Cannabis Stock I’d Buy Today

If you were to say that Aphria Inc. (TSX:APHA)(NYSE:APHA) was going to be my top cannabis stock a year ago, I would have laughed. A year ago, the situation was very different for this top pot stock. The company was mired in controversy, with the word “acquisition” even being thrown around now and again. Today, however, with the COVID-19 pandemic striking all…

Read More

3 Smoking-Hot Cannabis 2.0 Stocks That Could Grow Tenfold Over the Next Decade

The Canadian cannabis market shifted into a new gear with the launch of Cannabis 2.0 products in late 2019. Cannabis 2.0 products include edibles, extracts, and vaporizers. This segment of the cannabis market carries with it much higher profit margins than dried flower products do. Companies and investors are thus cautiously optimistic about a second green rush occurring. These three…

Read More

This Pot Stock Could Go From $400 Million to $4 Billion

Hexo Corp (TSX:HEXO)(NYSE:HEXO) isn’t a big pot stock. It’s worth only $400 million. Many of its competitors are worth several billion dollars. But if you’re looking for big upside, this is the stock for you. It all comes down to strategy. From the start, Hexo took a unique route. The rest of the industry followed a traditional path. This is…

Read More

This Pot Stock Just Revealed 2 Major Announcements

Pot stocks are a proven way to make money. In 2018, many skyrocketed in value by more than 1,000%. To be sure, cannabis is also a proven way to lose money. The marijuana bear market of 2019, for example, saw the industry lose half of its value in a matter of months. Long term, however, the biggest gains are still…

Read More

Should You Invest $1,000 in Cannabis Stocks Right Now?

The cannabis sector has experienced a bumpy ride over the past year. Investors who were late to the party and invested money in 2019 are likely nursing significant losses. However, right now could be an opportune time to invest in cannabis stocks, given the negative sentiment in the sector. Let’s take a look at three top Canadian names in this…

Read More

Canopy (TSX:WEED) and Aurora (TSX:ACB): Two Industry Juggernauts With Very Different Strategies

As the Canadian cannabis space has begun to enter a new phase, it is interesting to look back at how we got here. An initial frantic arms race to accumulate as much production capacity as possible eventually gave way to the reality that demand would be a lot slower to migrate to the legal market than market participants had hoped.…

Read More

Buy Alert: Molson Coors (TSX:TPX.B) Might Buy This Pot Stock

Molson Coors Canada Inc. (TSX:TPX.B)(NYSE:TAP) is a Canadian icon.  Last year, it generated more than $10 billion in sales. But there’s a problem: growth has stagnated. Last quarter, revenue declined by 8.7% year over year. “After a corporate restructuring in the fourth quarter of 2019 and a bevy of new products hitting the market in the New Year, Molson Coors…

Read More

Should You Buy Canopy Growth (TSX:WEED) or Aurora Cannabis (TSX:ACB) Stock?

Everyone knows that diversification is key to investing, as it protects investors from too much exposure into one specific sector. Having cannabis stocks in your portfolio may be a great idea if you are looking for a well-rounded portfolio. In Canada, marijuana has been legalized for medical use since 2001 and recreational use since 2018. This has allowed the industry…

Read More

HEXO Finds a New Market: Should Cannabis Investors Celebrate?

Cannabis producer HEXO (TSX:HEXO)(NYSE:HEXO) announced its first-ever product export to Israel on Thursday. The company has finally found a new market for medical marijuana after several quarters of declining segment sales. A recovering HEXO stock surged more than 5% on the news as investors took notice. However, should the market celebrate this latest win? What happened? HEXO has entered a 24-month…

Read More

Big Tobacco Is Betting $2 Billion on This Pot Stock

Altria Group (NYSE:MO) is one of the largest tobacco producers in the world. Its size is truly remarkable. Last quarter, despite the onset of the COVID-19 pandemic, the company generated more than $5 billion in sales. It also produced a quarterly profit of nearly $2 billion, up 38% year over year. Those profits help service an 8.6% dividend. If you…

Read More